Powering the future of diagnostic imaging
Nextrast is developing new classes of CT contrast agents that simplify imaging and reduce technical and interpretive errors. These agents enable detailed, high-quality scans even in traditionally challenging patient scenarios.
Explore our solutions
THE PROBLEM
Existing clinical contrast agents fail to meet today's clinical needs
Despite decades of progress across healthcare, the contrast agents used in medical imaging have remained unchanged for over 70 years. The result is that we have become accustomed to poor-quality scans and compromises when it comes to medical imaging.
Nextrast is setting new standards for medical imaging
We believe that the current landscape of contrast agents is inadequate. Patients deserve access to a better standard of care.
Learn more about our mission
Our Solutions
Nextrast
A dark oral contrast agent designed to darken the bowel lumen, creating a high-contrast environment that makes detailed bowel anatomy and tumors pop.
Learn more about NX9
Nextrast
A non-iodinated IV contrast agent that sustains its brightness for minutes, eliminating mis-timed scans, and reveals fine vascular detail and small tumors, even in plus-sized patients.
Learn more about NX10
In the News
New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial data show
Mayo Clinic News Network
Jan 20, 2026
New oral contrast agent helps spot ‘previously impossible-to-detect’ findings on CT
Radiology Business
Jan 21, 2026
UW, Mayo Clinic test new agent to improve CT scans
Becker’s Hospital Review
Jan 22, 2026
